March 11 (Reuters) - A federal judge has ruled in favor

of Merck ( MRK ) in litigation accusing the drugmaker of

concealing the risks of Gardasin, a vaccine to prevent cervical

and other fatal cancers.

The decision was made public on Tuesday by U.S. District

Judge Kenneth Bell in Charlotte, North Carolina.

(Reporting by Jonathan Stempel in New York)